Navigation Links
Mayo Clinic identifies a key cellular pathway in prostate cancer
Date:2/10/2014

ROCHESTER, Minn. Mayo Clinic researchers have shed light on a new mechanism by which prostate cancer develops in men. Central to development of nearly all prostate cancer cases are malfunctions in the androgen receptor the cellular component that binds to male hormones. The research team has shown that SPOP, a protein that is most frequently mutated in human prostate cancers, is a key regulator of androgen receptor activity that prevents uncontrolled growth of cells in the prostate and thus helps prevent cancer. The findings appear in the journal Cell Reports.

"By uncovering this new and important pathway of androgen receptor destruction, we may one day be able to develop more effective treatments for a substantial proportion of prostate cancer patients who have developed resistance to standard antiandrogen therapy," says Haojie Huang, Ph.D., Mayo Clinic biochemist and senior author of the paper.

SPOP mutations have been detected in approximately 15 percent of prostate cancer cases. In addition, it has been shown that in about 35 percent of prostate cancers, the SPOP protein is expressed at abnormally low levels. Despite its prevalence in prostate cancer, it was not known whether or how SPOP defects contributed to tumor development. What the research team discovered is that SPOP is an enzyme that selectively destroys androgen receptor protein. Failure to do so due to alterations in SPOP results in overabundance of androgen receptor, a master regulator of prostate cancer cell growth.

The Mayo Clinic research team made four major discoveries:

  • The antiandrogen receptor is a bona fide degradation substrate of SPOP.
  • Androgen receptor splicing variants are resistant to SPOP-mediated degradation.
  • Prostate cancer-associated SPOP mutants cannot bind to and promote androgen receptor degradation.
  • Androgens antagonize, but antiandrogens promote SPOP-mediated degradation of androgen receptor.

Pro
'/>"/>

Contact: Robert Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
2. First targeted nanomedicine to enter human clinical studies
3. Clinical insight improves treatment with new lung cancer drug
4. Clinical news alert from the American Academy of Orthopaedic Surgeons
5. Mayo Clinic launches whole genome breast cancer study
6. Mayo Clinic offers newly approved treatment for acid reflux disease
7. NYU Langone experts present research, clinical advances at neurosurgeons meeting
8. Mayo Clinic breast cancer study finds new type of mutation
9. Kroenke honored for outstanding contributions in clinical research training
10. Awards celebrate clinical research that can improve health and alleviate suffering
11. Association for Psychological Science, SAGE launch Clinical Psychological Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... 31, 2015 , ... The Lisle family law firm of Momkus McCluskey, ... by his peers to earn a “Leading Lawyers” distinction. , The ... state of Illinois. The nomination process is based on statewide peer survey nominations and ...
(Date:8/31/2015)... ... August 31, 2015 , ... Patients who thought about getting a hair transplant ... learning more about the procedure beyond the information found on the Internet can attend ... surgeon Parsa Mohebi will be on hand to answer patients hair transplant questions at ...
(Date:8/31/2015)... ... September 01, 2015 , ... ... for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy ”. , ... Traumatic brain injury has been largely untreatable - with mostly palliative treatments only ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Dr. Paul ... “NJ Top Doc.” , At OSSMC, Dr. Kovatis treats all surgical and non-surgical disorders ... traumatic injuries to the entire musculoskeletal system, excluding the spine. , Dr. Paul Kovatis ...
(Date:8/31/2015)... ... August 31, 2015 , ... Diablo Publications ... that it has officially launched a new website and company identity ( diablopublications.com) ... are more closely aligned with the company’s strategic vision for growth and expansion ...
Breaking Medicine News(10 mins):Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
... Thompson HealthDay Reporter , THURSDAY, Dec. 29 (HealthDay ... probably first had blood tests, an imaging test like an ... "Is all this really necessary?" you might have wondered. ... a growing body of evidence suggests that overuse of diagnostic ...
... ovarian cancer with the drug bevacizumab ("Avastin") delays the disease ... international clinical trial co-led by Drs. Amit Oza of the ... St James,s Institute of Oncology, Leeds, UK. The ... Medicine, report that the drug halted the cancer,s return ...
... WEDNESDAY, Dec. 28 (HealthDay News) -- Severely ill hospital patients ... and often wear compression stockings and/or take blood thinners to ... Lovenox (enoxaparin) to the mix does not reduce their ... appearing in the Dec. 29 issue of the New ...
... News) -- Disease-causing strains of the fungus Fusarium ... common source of infection in humans, according to a new ... diseases in agricultural crops, but some species of the fungus ... For example, Fusarium was the cause of ...
... Dennis Thompson HealthDay Reporter , WEDNESDAY, Dec. 28 ... but old-fashioned letter-writing may have a more beneficial lasting effect ... war zones, most in Iraq, researchers found that letters from ... onto paper or typed into an email -- served as ...
... -- Regular beer and even some brands of beer labeled ... for people with celiac disease, a new study says. ... gluten called hordein. However, some beer companies contend that the ... levels, according to a release from the Journal of ...
Cached Medicine News:Health News:Is American Medicine Too Test Happy? 2Health News:Is American Medicine Too Test Happy? 3Health News:Ovarian cancer study proves drug delays disease progression, may improve survival 2Health News:Adding Lovenox Didn't Reduce Blood Clot Death Risk in Study 2Health News:Fungus Found in Sinks Can Cause Serious Infections 2Health News:In High-Tech Age, the Good Old Letter Still Holds Sway 2Health News:In High-Tech Age, the Good Old Letter Still Holds Sway 3
(Date:8/31/2015)...  Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX ), a ... of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, ... four investor conferences in September. , ... Company, LLC Emerging Growth Conference in ... , President & Chief Executive Officer, will present a ...
(Date:8/31/2015)... Israel , August 31, 2015 ... (TASE: BOLT, OTCQX: BLGTY) ("BioLight" or the ... commercializes biomedical innovations in ophthalmology and cancer diagnostics, ... Technologies (TASE: MCTC), has identified several new genetic ... the jawbone in patients treated with bisphosphonate drugs ...
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Asterias ... focused on the emerging field of regenerative medicine, ... dosed at Chicago -based Rush ... trial evaluating activity of escalating doses of AST-OPC1 ... sensory and motor complete cervical spinal cord injury ...
Breaking Medicine Technology:Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6
... , NEW YORK ... (Sony) announced today that it has acquired iCyt Mission Technology, Inc. ... cell and disease research, through its U.S. subsidiary, Sony Corporation of ... technologies to enter the flow cytometry business in the life science ...
... , Feb. 9 STD Med, Inc., a manufacturer ... is pleased to announce the acquisition of a new 32,000 sq. ... addition to the current footprint of 120,000 sq. ft. "We are ... financial times," said Steven Tallarida , President STD Med, "we ...
Cached Medicine Technology:Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt 2Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt 3STD Med Inc. Acquires Facility for Manufacturing and Start-Ups 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: